e-Drug3D

2143

FOSLEVODOPA


INN
FOSLEVODOPA

(has an active metabolite)

cas 97321-87-4
CLASS

NERVOUS SYSTEM
ANTIPARKINSONIAN
ANTIDYSKINETICS
METABOLIC PRECURSOR OF DOPAMINE

ROUTE (list)

SUBCUTANEOUS

ATC code

N04BA01
N04BA02
N04BA03

PK parameters

PPB 25 PERCENT

Solubility

FREELY SOLUBLE IN WATER


Target

TARGET ALKALINE PHOSPHATASE

DrugCentral

-

Download SDF file L-Tyrosine, 3-hydroxy-O-phosphono- (ACI)

Formula:
C9H12NO7P

Calculated chemical properties:

MW 274.14
NB_atoms 18
XLogP -2.78
PSA 147.377
NB_HD 3
NB_HA 8
fsp3 0.22
Lipinski(0=no;1=yes) 0

FDA
NDA 216962 (label) INN (FOSCARBIDOPA ; FOSLEVODOPA) VYALEV (ABBVIE) APPROVAL= AP YEAR= 2024

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL